I think this is right, Toe. When the PR for SVFC is repeated, if the 10K and Q are reasonable/positive, hires for the CFO and CEO are accomplished, and more articles hit the wires, then the spin will change. I don't think we'll be arguing about it being a subpenny stock anymore. (my opinion) Until then, what else do spinners have to do...but look for weaknesses in armor. That's okay with me. It's part of the game.
As for me, I went there, had my question carefully answered, read all of the documents BBW and everyone else keeps tossing, carefully reviewed the science (I'm qualified to do this), and decided that it was worth staying in long.
Now, if they EVENTUALLY (yawn) won $ for damages, I'd be happy for them. I'd be happier if they start ramping up revenues from demand from their one (and eventually 2) labs.
I'll be honest, I'm hoping Merck, etc buys them.
j
